Get started
CHIMERIC THERAPEUTICS LIMITEDCHIMERIC THERAPEUTICS LIMITEDCHIMERIC THERAPEUTICS LIMITED

CHIMERIC THERAPEUTICS LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

CHM chart


Full chart

CHM upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.45 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.013 AUD
Net income (FY)
‪−12.53 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
‪1.30 B‬
Beta (1Y)
1.31

About CHIMERIC THERAPEUTICS LIMITED


Sector
Health Technology
Industry
Biotechnology
CEO
Rebecca McQualter
Website
chimerictherapeutics.com
Headquarters
Carlton
Founded
2020
ISIN
AU0000121576
FIGI
BBG00YD0SSH0
Chimeric Therapeutics Ltd. is a clinical stage cell therapy company, which engages in the development and commercialization of cell therapies in oncology. Its products include NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company was founded by Paul A. Hopper in 2020 and is headquartered in Carlton South, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CHM news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CHM is 0.006 AUD — it hasn't changed in the past 24 hours. Watch CHIMERIC THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange CHIMERIC THERAPEUTICS LIMITED stocks are traded under the ticker CHM.
CHM stock has fallen by −14.29% compared to the previous week, the month change is a −40.00% fall, over the last year CHIMERIC THERAPEUTICS LIMITED has showed a −78.57% decrease.
CHM reached its all-time high on Jan 21, 2021 with the price of 0.424 AUD, and its all-time low was 0.006 AUD and was reached on Dec 11, 2024. View more price dynamics on CHM chart.
See other stocks reaching their highest and lowest prices.
CHM stock is 16.67% volatile and has beta coefficient of 1.31. Track CHIMERIC THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is CHIMERIC THERAPEUTICS LIMITED there?
Today CHIMERIC THERAPEUTICS LIMITED has the market capitalization of ‪9.45 M‬, it has decreased by −14.29% over the last week.
Yes, you can track CHIMERIC THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
CHIMERIC THERAPEUTICS LIMITED is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
CHM net income for the last half-year is ‪−14.97 M‬ AUD, while the previous report showed ‪2.44 M‬ AUD of net income which accounts for −712.68% change. Track more CHIMERIC THERAPEUTICS LIMITED financial stats to get the full picture.
No, CHM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CHM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHIMERIC THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHIMERIC THERAPEUTICS LIMITED technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHIMERIC THERAPEUTICS LIMITED stock shows the sell signal. See more of CHIMERIC THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.